Marketing Science Associate Director, CGT

Boston, MA (Hybrid)

$158K/yr – $237K/yrSenior Level8+ years expFull time

Posted 1 month ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own the insights and analytics backbone for brand and launch planning, turning research into clear recommendations for strategy and forecast inputs.

  • Joint-workstream: Define and execute a plan that turns primary market research and analytics into actionable business insights across marketing and strategy.
  • Research and analytics ownership: Independently design primary studies and specify analytics needs to support ongoing questions and the Long-Range Plan.
  • Cross-functional governance: Lead the analytics coordination forum and maintain an Insights book to keep stakeholders aligned.

Job Description

Responsibilities

  • Function as a key partner to Marketing and Global Commercial Strategy colleagues and provide objective perspective and insights
  • Formulate a comprehensive insights generation plan to address a spectrum of business questions using appropriate methodologies
  • Independently design and execute primary market research that addresses key business questions
  • Define data analytics needed to answer ongoing business questions and support/oversee its execution
  • Run the analytics coordination forum which provides cross-functional alignment on analytics activities supporting the program
  • Maintain a current summary of all the insights supporting a disease area in the form of an Insights book
  • Develop the situation analysis for the Brand Planning process
  • Maintain a strong understanding of the LRP forecast model and provide assumptions that inform the Long-Range Plan

Benefits

  • From medical, dental and vision benefits to generous paid time off (including a week-long company shutdown in the Summer and the Winter), educational assistance programs including student loan repayment, a generous commuting subsidy, matching charitable donations, 401(k) and so much more.
Vertex Pharmaceuticals logo

Vertex Pharmaceuticals

4.2 Glassdoor

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and has made significant advancements in multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, and acute pain — and continues to progress clinical and research programs in these diseases. We also have a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where we have deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency. Our global headquarters is in Boston, and we have research and development (R&D) sites and commercial offices worldwide.Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. We have also earned a spot on TIME Most Influential Companies, TIME Best Inventions, and Fast Company Most Innovative Companies lists. Our research and medicines have received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the Prix Galien, the Scrip Award and the Breakthrough Prize awards.Read our community guidelines: https://www.vrtx.com/vertexs-community-guidelines/

Founded in 1989
Boston, Massachusetts, USA
6.1K employees (282 in marketing)
83% recommend to a friend
88% CEO approval

Traffic Signals

Monthly Visitors
340.5K
Monthly Google Ads Budget
$44.9K
Traffic Source Mix
Search
36.6%
Direct
38.5%
Referral
22.7%
Social
1%
Paid
1.1%

Headcount Trend

Current headcount: ~6.2K

Marketing Team

Marketing Team Size
258 (4% of company)
Median Career Experience
14 years
Median Tenure
3.8 years

Funding

Total Funding
$657.3M
Last Raise
$1.1M
Post IPO Secondary, 2 years ago

Funding History

  • Jul 2024
    Post IPO Secondary • $1.1M
  • May 2022
    Post IPO Equity • $50M
  • Dec 2009
    Post IPO Equity • $443M

Recent News